Your shopping cart is currently empty

Polyethylene glycol (PEG) is approved by the FDA for use as a carrier or matrix in foods, cosmetics, and pharmaceuticals, including injectable, topical, rectal, and nasal formulations. PEG exhibits minimal toxicity and can be fully excreted from the body via the kidneys (for PEG <30 kDa) or feces (for PEG >20 kDa). It is non-immunogenic, and antibodies to PEG only develop in rabbits when PEG is combined with highly immunogenic proteins.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 g | Inquiry | Inquiry | Inquiry | |
| 5 g | Inquiry | Inquiry | Inquiry | |
| 10 g | Inquiry | Inquiry | Inquiry |
| Description | Polyethylene glycol (PEG) is approved by the FDA for use as a carrier or matrix in foods, cosmetics, and pharmaceuticals, including injectable, topical, rectal, and nasal formulations. PEG exhibits minimal toxicity and can be fully excreted from the body via the kidneys (for PEG <30 kDa) or feces (for PEG >20 kDa). It is non-immunogenic, and antibodies to PEG only develop in rabbits when PEG is combined with highly immunogenic proteins. |
| Synonyms | Polyethylene glycol 3000, PEG3000 |
| Molecular Weight | 3000 |
| Storage | keep away from moisture | store at 4°C |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.